Farms.com Home   News

American Feed Industry Association Applauds Congress' Confirmation of Scott Gottlieb to Lead FDA

American Feed Industry Association Applauds Congress' Confirmation of Scott Gottlieb to Lead FDA
 
“The American Feed Industry Association applauds Congress’ decision today to confirm Scott Gottlieb to lead the Food and Drug Administration. AFIA has patiently waited for this pivotal role to be filled, as FDA is the main agency surrounding the regulation of animal food and animal drugs used in feed. 
 
“Commissioner Gottlieb has an extensive medical resume, and AFIA plans to grow his awareness on animal food issues. Some of our primary goals involve working with the new commissioner to speed up ingredient approvals and lessen the regulatory burden presented by the Food Safety Modernization Act and Veterinary Feed Directive, two major rules that are in implementation periods. Both rules prove costly and complicated to the animal food industry, with the cost to benefit ratio lacking on the benefit side. AFIA hopes regulatory relief will be offered by the new administration and strongly believes we can achieve both ensuring feed/food safety for animals and consumers, as well as practical implementation requirements for the industry.
Click here to see more...

Trending Video

New discovery may lead to better vaccines for pork producers

Video: New discovery may lead to better vaccines for pork producers



Porcine reproductive and respiratory syndrome virus (PRRSV) causes severe disease in pigs, leading to significant economic losses for pork producers across the globe. It’s estimated that PRRS costs the Canadian pork industry $130M annually. Using the CMCF beamline, researchers from the University of Manitoba and the Leiden University Medical Centre (Netherlands) were able to see the structure of the PRRSV protease, a type of protein the pathogen uses to suppress a host’s immune system. The vital information they uncovered can be used to develop new vaccines against PRRSV and also helps inform development of vaccines against emerging human viruses.